A systematic review reporting quality of radiomics research in neuro-oncology: toward clinical utility and quality improvement using high-dimensional imaging features.

Abstract:

BACKGROUND:To evaluate radiomics analysis in neuro-oncologic studies according to a radiomics quality score (RQS) system to find room for improvement in clinical use. METHODS:Pubmed and Embase were searched up the terms radiomics or radiogenomics and gliomas or glioblastomas until February 2019. From 189 articles, 51 original research articles reporting the diagnostic, prognostic, or predictive utility were selected. The quality of the methodology was evaluated according to the RQS. The adherence rates for the six key domains were evaluated: image protocol and reproducibility, feature reduction and validation, biologic/clinical utility, performance index, a high level of evidence, and open science. Subgroup analyses for journal type (imaging vs. clinical) and biomarker (diagnostic vs. prognostic/predictive) were performed. RESULTS:The median RQS was 11 out of 36 and adherence rate was 37.1%. Only 29.4% performed external validation. The adherence rate was high for reporting imaging protocol (100%), feature reduction (94.1%), and discrimination statistics (96.1%), but low for conducting test-retest analysis (2%), prospective study (3.9%), demonstrating potential clinical utility (2%), and open science (5.9%). None of the studies conducted a phantom study or cost-effectiveness analysis. Prognostic/predictive studies received higher score than diagnostic studies in comparison to gold standard (P < .001), use of calibration (P = .02), and cut-off analysis (P = .001). CONCLUSIONS:The quality of reporting of radiomics studies in neuro-oncology is currently insufficient. Validation is necessary using external dataset, and improvements need to be made to feature reproducibility, demonstrating clinical utility, pursuits of a higher level of evidence, and open science.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Park JE,Kim HS,Kim D,Park SY,Kim JY,Cho SJ,Kim JH

doi

10.1186/s12885-019-6504-5

subject

Has Abstract

pub_date

2020-01-10 00:00:00

pages

29

issue

1

issn

1471-2407

pii

10.1186/s12885-019-6504-5

journal_volume

20

pub_type

杂志文章,meta分析
  • Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer.

    abstract:BACKGROUND:The neutrophil-to-lymphocyte ratio (NLR), a simple marker of the systemic inflammatory response in critical care patients, has been suggested as an independent prognostic factor for several solid malignancies. We investigated the utility of pretreatment NLR as a prognosticator in patients who presented with ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2134-3

    authors: Kawahara T,Yokomizo Y,Ito Y,Ito H,Ishiguro H,Teranishi J,Makiyama K,Miyoshi Y,Miyamoto H,Yao M,Uemura H

    更新日期:2016-02-16 00:00:00

  • The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy.

    abstract:BACKGROUND:The prognostic value of rectal invasion is still unclear in stage IVA cervical cancer. The objective of this study is to evaluate patient outcome and prognostic factors in stage IVA cervical cancer treated with radiation therapy. METHODS:A retrospective review of the medical records of patients treated with...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2268-3

    authors: Wakatsuki M,Kato S,Kiyohara H,Ohno T,Karasawa K,Tamaki T,Ando K,Shiba S,Kamada T,Nakano T

    更新日期:2016-03-23 00:00:00

  • Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937.

    abstract:BACKGROUND:Breast cancer is the second leading cause of cancer deaths in women in the United States. Although the causes of this disease are incompletely understood, oxidative DNA damage is presumed to play a critical role in breast carcinogenesis. A common oxidatively induced DNA lesion is 8-hydroxyguanine (8-OH-Gua),...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-297

    authors: Nyaga SG,Lohani A,Jaruga P,Trzeciak AR,Dizdaroglu M,Evans MK

    更新日期:2006-12-27 00:00:00

  • Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma.

    abstract:BACKGROUND:The efficacy of immunotherapy targeting the PD-1/PD-L1 pathway has previously been demonstrated in metastatic head and neck squamous cell carcinoma (HNSCC). Stereotactic Body Radiotherapy (SBRT) aims at ablating metastatic lesions and may play a synergistic role with immunotherapy. The purpose of this study ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5266-4

    authors: Bahig H,Aubin F,Stagg J,Gologan O,Ballivy O,Bissada E,Nguyen-Tan FP,Soulières D,Guertin L,Filion E,Christopoulos A,Lambert L,Tehfe M,Ayad T,Charpentier D,Jamal R,Wong P

    更新日期:2019-01-14 00:00:00

  • The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.

    abstract:BACKGROUND:C3H mice have been frequently used in cancer studies as animal models of spontaneous liver tumors and chemically induced hepatocellular carcinoma (HCC). Epigenetic modifications, including DNA methylation, are among pivotal control mechanisms of gene expression leading to carcinogenesis. Although information...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4221-0

    authors: Matsushita J,Okamura K,Nakabayashi K,Suzuki T,Horibe Y,Kawai T,Sakurai T,Yamashita S,Higami Y,Ichihara G,Hata K,Nohara K

    更新日期:2018-03-22 00:00:00

  • Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response.

    abstract:BACKGROUND:Genomic initiatives such as The Cancer Genome Atlas (TCGA) contain data from -omics profiling of thousands of tumor samples, which may be used to decipher cancer signaling, and related alterations. Managing and analyzing data from large-scale projects, such as TCGA, is a demanding task. It is difficult to di...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5965-x

    authors: Lucchetta M,da Piedade I,Mounir M,Vabistsevits M,Terkelsen T,Papaleo E

    更新日期:2019-08-20 00:00:00

  • Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study.

    abstract:BACKGROUND:Human Papillomavirus (HPV) genotyping has an increasingly important role in cervical cancer screening and vaccination monitoring, however, without an internationally agreed standard reference assay. The test results from the most widely used genotyping assays are read manually and hence prone to inter-observ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1223-z

    authors: Ejegod DM,Rebolj M,Bonde J

    更新日期:2015-04-02 00:00:00

  • Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient.

    abstract:BACKGROUND:Ovarian carcinoma is a common, and often deadly, gynecological cancer. Mutations in BRCA1 and BRCA2 genes are present in at least a fifth of patients. Uncovering other genes that become mutated subsequent to BRCA1/BRCA2 inactivation during cancer development will be helpful for more effective treatments. ME...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-146

    authors: Zhang J,Shi Y,Lalonde E,Li L,Cavallone L,Ferenczy A,Gotlieb WH,Foulkes WD,Majewski J

    更新日期:2013-03-22 00:00:00

  • Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.

    abstract:BACKGROUND:Little is known about the relationship between the metabolite profile of plasma from pre-operative prostate cancer (PCa) patients and the risk of PCa progression. In this study we investigated the association between pre-operative plasma metabolites and risk of biochemical-, local- and metastatic-recurrence,...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6418-2

    authors: Zoni E,Minoli M,Bovet C,Wehrhan A,Piscuoglio S,Ng CKY,Gray PC,Spahn M,Thalmann GN,Kruithof-de Julio M

    更新日期:2019-12-16 00:00:00

  • Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study.

    abstract:BACKGROUND:Whether chronic inflammation increases prostate cancer risk remains unclear. This study investigated whether chronic inflammatory diseases (CID) or anti-inflammatory medication use (AIM) were associated with prostate cancer risk. METHODS:Fifty-five thousand nine hundred thirty-seven cases (all prostate canc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5846-3

    authors: Beckmann K,Russell B,Josephs D,Garmo H,Haggstrom C,Holmberg L,Stattin P,Van Hemelrijck M,Adolfsson J

    更新日期:2019-06-21 00:00:00

  • Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy.

    abstract:BACKGROUND:Interleukin 12 (IL-12) is a cytokine that has been reported to exhibit potent tumoricidal effects in animal tumor models. A combined approach using Paclitaxel and platinum-based doublet chemotherapy is the most commonly used backbone regimen for treating lung cancer. Despite numerous studies regarding the an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2701-7

    authors: Yue T,Zheng X,Dou Y,Zheng X,Sun R,Tian Z,Wei H

    更新日期:2016-08-22 00:00:00

  • Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study.

    abstract:BACKGROUND:High-risk Human Papillomavirus (HPV) testing is replacing cytology in cervical cancer screening as it is more sensitive for preinvasive cervical lesions. However, the bottleneck of HPV testing is the many false positive test results (positive tests without cervical lesions). Here, we evaluated to what extent...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2518-4

    authors: Preisler S,Rebolj M,Ejegod DM,Lynge E,Rygaard C,Bonde J

    更新日期:2016-07-20 00:00:00

  • Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT).

    abstract:BACKGROUND:The impact of local tumor ablative therapy in oligometastasized prostate cancer (PC) is still under debate. To gain data for this approach, we evaluated oligometastasized PC patients receiving stereotactic body radiotherapy (SBRT) to bone metastases. METHODS:In this retrospective study, 15 oligometastasized...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3341-2

    authors: Habl G,Straube C,Schiller K,Duma MN,Oechsner M,Kessel KA,Eiber M,Schwaiger M,Kübler H,Gschwend JE,Combs SE

    更新日期:2017-05-22 00:00:00

  • Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging.

    abstract:BACKGROUND:Merkel cell carcinoma (MCC) is a rare cutaneous neoplasm with increasing incidence, aggressive behavior and poor prognosis. Somatostatin receptors (SSTR) are expressed in MCC and represent a potential target for both imaging and treatment. METHODS:To non-invasively assess SSTR expression in MCC using PET an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-268

    authors: Buder K,Lapa C,Kreissl MC,Schirbel A,Herrmann K,Schnack A,Bröcker EB,Goebeler M,Buck AK,Becker JC

    更新日期:2014-04-17 00:00:00

  • Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.

    abstract:BACKGROUND:The association of reproductive factors with hormone receptor (HR)-negative breast tumors remains uncertain. METHODS:Within the EPIC cohort, Cox proportional hazards models were used to describe the relationships of reproductive factors (menarcheal age, time between menarche and first pregnancy, parity, num...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-13-584

    authors: Ritte R,Tikk K,Lukanova A,Tjønneland A,Olsen A,Overvad K,Dossus L,Fournier A,Clavel-Chapelon F,Grote V,Boeing H,Aleksandrova K,Trichopoulou A,Lagiou P,Trichopoulos D,Palli D,Berrino F,Mattiello A,Tumino R,Sacerdote

    更新日期:2013-12-09 00:00:00

  • Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway.

    abstract:BACKGROUND:Genistein has been known to inhibit proliferation and induce apoptosis in several kinds of cancer cells. While knowledge of genistein in regulating epithelial mesenchymal transition (EMT) of colon cancer cells is unknown. METHODS:To investigate the effects and mechanisms of genistein on EMT of colon cancer ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3829-9

    authors: Zhou P,Wang C,Hu Z,Chen W,Qi W,Li A

    更新日期:2017-12-04 00:00:00

  • Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.

    abstract:BACKGROUND:Toll-like receptors (TLRs) have garnered an extraordinary amount of interest in cancer research due to their role in tumor progression. By activating the production of several biological factors, TLRs induce type I interferons and other cytokines, which drive an inflammatory response and activate the adaptiv...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-665

    authors: González-Reyes S,Marín L,González L,González LO,del Casar JM,Lamelas ML,González-Quintana JM,Vizoso FJ

    更新日期:2010-12-03 00:00:00

  • A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer patients with PS 2 up to 74 years old and patients with PS 0 or 1 from 75 years: NEJ039A (trial in progress).

    abstract:BACKGROUND:Durvalumab is a standard drug used during maintenance therapy after chemoradiotherapy in patients with locally advanced non-small cell lung cancer (LA-NSCLC). However, little is known about the clinical benefits of durvalumab after chemoradiotherapy in patients with LA-NSCLC with a performance status (PS) of...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07406-y

    authors: Kaira K,Mouri A,Kato S,Yoshimura K,Kagamu H,Kobayashi K

    更新日期:2020-10-06 00:00:00

  • Extragenital Müllerian adenosarcoma with pouch of Douglas location.

    abstract:BACKGROUND:Of all female genital tract tumors, 1-3% are stromal malignancies. In 8-10% of cases, these are represented by Müllerian adenosarcoma an extremely rare tumor characterized by a stromal component of usually low-grade malignancy and by a benign glandular epithelial component. Variant that arises in the pouch o...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-171

    authors: Patrelli TS,Silini EM,Gizzo S,Berretta R,Franchi L,Thai E,Lukanovic A,Nardelli GB,Modena AB

    更新日期:2011-05-15 00:00:00

  • Napsin A as a marker of clear cell ovarian carcinoma.

    abstract:BACKGROUND:Clear cell carcinomas are aggressive tumors with a distinct biologic behaviour. In a genome-wide screening for genes involved in chemo-resistance, NAPA was over-expressed in cisplatin-resistant cells. The NAPA (protein) Napsin A was described to promote resistance to cisplatin by degradation of the tumor sup...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-524

    authors: Skirnisdottir I,Bjersand K,Akerud H,Seidal T

    更新日期:2013-11-05 00:00:00

  • Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder.

    abstract:BACKGROUND:Carcinoma in situ (CIS) is believed to be a precursor of invasive bladder cancer. Identification of CIS is a valuable prognostic factor since radical treatment strategies can be offered these patients before the disease becomes invasive. METHODS:We developed a pathway based classifier approach to predict pr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-37

    authors: Herbsleb M,Christensen OF,Thykjaer T,Wiuf C,Borre M,Orntoft TF,Dyrskjøt L

    更新日期:2008-01-31 00:00:00

  • The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells.

    abstract:BACKGROUND:RhoC is a small G protein/GTPase and involved in tumor mobility, invasion and metastasis. Previously, up-regulated RhoC expression is found to play an important role in ovarian carcinogenesis and subsequent progression by modulating proliferation, apoptosis, migration and invasion. METHODS:We transfected Rh...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-477

    authors: Gou WF,Zhao Y,Lu H,Yang XF,Xiu YL,Zhao S,Liu JM,Zhu ZT,Sun HZ,Liu YP,Xu F,Takano Y,Zheng HC

    更新日期:2014-07-01 00:00:00

  • Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea.

    abstract:BACKGROUND:Smoking is by far the most important cause of cancer that can be modified at the individual level. Cancer incidence and mortality rates in Korea are the highest among all Asian countries, and smoking prevalence in Korean men is one of the highest in developed countries. The purpose of the current study was t...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析,评审

    doi:10.1186/1471-2407-14-406

    authors: Park S,Jee SH,Shin HR,Park EH,Shin A,Jung KW,Hwang SS,Cha ES,Yun YH,Park SK,Boniol M,Boffetta P

    更新日期:2014-06-06 00:00:00

  • Breast and cervical cancer screening services in Malawi: a systematic review.

    abstract:BACKGROUND:To identify and to assess factors enhancing or hindering the delivery of breast and cervical cancer screening services in Malawi with regard to accessibility, uptake, acceptability and effectiveness. METHODS:Systematic review of published scientific evidence. A search of six bibliographic databases and grey...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07610-w

    authors: Pittalis C,Panteli E,Schouten E,Magongwa I,Gajewski J

    更新日期:2020-11-12 00:00:00

  • Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.

    abstract:BACKGROUND:High invasion and metastasis are the primary factors causing poor prognosis of patients with hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying these biological behaviors have not been completely elucidated. In this study, we investigate the molecular mechanism by which hypoxia prom...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-108

    authors: Zhang L,Huang G,Li X,Zhang Y,Jiang Y,Shen J,Liu J,Wang Q,Zhu J,Feng X,Dong J,Qian C

    更新日期:2013-03-09 00:00:00

  • Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer.

    abstract:BACKGROUND:In vitro and in vivo studies have suggested that osteopontin (OPN) is associated with many types of cancers. However, no studies have reported the incidence of OPN polymorphisms and the risk of gastric cancer. The aim of this study was to investigate the association between OPN polymorphisms and gastric canc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-477

    authors: Zhao F,Chen X,Meng T,Hao B,Zhang Z,Zhang G

    更新日期:2012-10-16 00:00:00

  • Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma.

    abstract:BACKGROUND:This study aimed to explore the heterogeneity of circRNA expression pattern via microarray, and further evaluate the potential of 10 specific circRNAs as diagnostic and prognostic biomarkers in multiple myeloma (MM). METHODS:In exploration stage (stage I), circRNA expression profiles were detected by the mi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6515-2

    authors: Zhou F,Wang D,Wei W,Chen H,Shi H,Zhou N,Wu L,Peng R

    更新日期:2020-01-16 00:00:00

  • Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice.

    abstract:BACKGROUND:Although cisplatin is one of the most effective chemotherapeutic agents, cisplatin alone does not achieve a satisfactory therapeutic outcome. Also cisplatin accumulation shows toxicity to normal tissues. In this study, we examined the possibility of HemoHIM both to enhance anticancer effect with cisplatin an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-85

    authors: Park HR,Ju EJ,Jo SK,Jung U,Kim SH,Yee ST

    更新日期:2009-03-17 00:00:00

  • The study protocol of the evaluation for the preventive efficacy of the HPV vaccine for persistent HPV16/18 infection in Japanese adult women: the HAKUOH study.

    abstract:BACKGROUND:In general, human papillomavirus (HPV) vaccines have demonstrated efficacy in young women worldwide, but there is limited evidence on the efficacy of the quadrivalent HPV6/11/16/18 vaccine in adult women and no evidence of its effectiveness in Japanese adult women in particular. This study aims to evaluate t...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07563-0

    authors: Kurokawa T,Yamamoto M,Onuma T,Tsuyoshi H,Shinagawa A,Chino Y,Yoshida Y

    更新日期:2020-11-03 00:00:00

  • Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis.

    abstract:BACKGROUND:The objective of this study was to describe the real-world treatment and overall survival (OS) of German patients with a diagnosis of advanced non-small cell lung cancer (aNSCLC), and to explore factors associated with the real-world mortality risk. METHODS:This was a retrospective German claims data analys...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06738-z

    authors: Hardtstock F,Myers D,Li T,Cizova D,Maywald U,Wilke T,Griesinger F

    更新日期:2020-03-30 00:00:00